Cayman

STING R232 variant (human, recombinant)

CHF 909.00
In stock
CAY-22816-100100 µgCHF 909.00
 
More Information
Product Details
Synonyms Endoplasmic Reticulum Interferon Stimulator; ERIS; hSTING; MITA; MPYS; Stimulator of Interferon Genes; TMEM173
Product Type Protein
Properties
Sequence Recombinant N-terminal His-tagged STING (R232 variant) catalytic domain purified from E. coli.
Purity ≥80% (SDS-PAGE)
Formulation 50 mM HEPES, pH 8.0, 150 mM sodium chloride, 10% glycerol
Other Product Data

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.

Declaration Manufactured by Cayman Chemicals.
Shipping and Handling
Shipping DRY ICE
Long Term Storage -80°C
Documents
MSDS Inquire
Product Specification Sheet
Datasheet Download PDF
Description
Stimulator of interferon genes (STING) is a component of the innate immune response that binds to cyclic dinucleotides, which are bacterial second messengers, leading to activation of NF-κB and transcription of immunomodulatory genes, including type I interferon (IFN). The H232 variant of STING is found at a 13.7% frequency in the 1000 Genome Project. The SNP variant R232 is the most common variant in the human population, found at a frequency of 57.9%. Various mutations in STING either reduce or increase its activity. Gain-of-function mutations in STING, including R284M and V155M, lead to constitutive activation and enhancement of the type I IFN response.
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.